Search
for
Sort by
Research 121–150 of 1000+
- Short‐ and Long‐Term Clinical Skin Effects of Testosterone Treatment in Trans Men
- Global Adiposity and Thickness of Intraperitoneal and Mesenteric Adipose Tissue Depots Are Increased in Women With Polycystic Ovary Syndrome (PCOS)
- Diagnosis of hyperandrogenism: clinical criteria
- Intracrinology and The Skin
- Side-Effects of Spironolactone Therapy in the Hirsute Woman
- Inhibition of skin 5α-reductase by oral contraceptive progestins<i>in vitro</i>
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Management of Hirsutism
- Minoxidil therapy in children with severe hypertension
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Role of insulin resistance and diet in acne
- Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman
- Patterns of ovarian morphology in polycystic ovary syndrome: a study utilising magnetic resonance imaging
- When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
- Cardiovascular risk factors and events in women with androgen excess
- The investigation and management of hirsutism
- A method to improve the efficacy of topical eflornithine hydrochloride cream
- Antiandrogen Therapy for Skin and Hair Disease
- Rabson-Mendenhall syndrome: two case reports and a brief review of the literature
- The 5alpha-reductase type 1, but not type 2, gene is expressed in anagen hairs plucked from the vertex area of the scalp of hirsute women and normal individuals
- Female Androgenic Alopecia
- Testosterone in Women: Measurement and Therapeutic Use
- “Osler’s phenomenon”: misdiagnosing Cushing’s syndrome
- [Hyperprolactinemia and hypophyseal hypothyroidism as cofactors in hirsutism and androgen-induced alopecia in women].
- Polycystic Ovary Syndrome: Features, Diagnostic Criteria and Treatments
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Cutaneous manifestations of polycystic ovary syndrome
- No. 350-Hirsutism: Evaluation and Treatment
- Serendipity in Trichology
- Urinary 5-ene-steroid excretion in non-classical congenital adrenal hyperplasia due to 3β-hydroxysteroid dehydrogenase deficiency (NC-3BHSD)